BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4293073)

  • 1. Studies with angiotensin in nephrogenic diabetes insipidus.
    Orr FR; Filipich RL
    Can Med Assoc J; 1967 Sep; 97(14):841-5. PubMed ID: 4293073
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrogenic diabetes insipidus. Effects of 3,5, cyclic-adenosine monophosphate.
    Jones NF; Barraclough MA; Barnes N; Cottom DG
    Arch Dis Child; 1972 Oct; 47(255):794-7. PubMed ID: 4343784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiotensin and saluretics in nephrogenic diabetes insipidus of early infancy].
    Reimold EW
    Z Kinderheilkd; 1967; 101(1):6-19. PubMed ID: 4301709
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of vasopressin-sensitive diabetes insipidus with chlorpropamide.
    Kunstadter RH; Cabana EC; Oh W
    Am J Dis Child; 1969 Apr; 117(4):436-41. PubMed ID: 5773412
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical value of the combination of vasopressin and chlorpropamide in a patient with "refractory" diabetes insipidus.
    Radó JP; Szende L; Takó J; Góth E; Fövényi J
    Endokrinologie; 1972 Feb; 59(2):203-12. PubMed ID: 5036075
    [No Abstract]   [Full Text] [Related]  

  • 6. Diuretic and antidiuretic effects of furosemide before and during the early period of pitressin therapy in diabetes insipidus.
    Radó JP; Takó J; Szabó T; Bános C
    Endokrinologie; 1969; 54(1):26-35. PubMed ID: 5358572
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation of the antidiuretic effect of vasopressin by chlorpropamide.
    Berndt WO; Miller M; Kettyle WM; Valtin H
    Endocrinology; 1970 May; 86(5):1028-32. PubMed ID: 5435244
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of hypopituitarism with diabetes insipidus and loss of thirst. Role of antidiuretic hormone and angiotensin II in the control of urine flow and osmolality.
    Trust PM; Brown JJ; Chinn RH; Lever AF; Morton JJ; Padfield PL; Robertson JI; Ireland JT; Melville ID; Thomson WS
    J Clin Endocrinol Metab; 1975 Aug; 41(2):346-53. PubMed ID: 1171897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of chlorpropamide in diabetes insipidus in children.
    Ehrlich RM; Kooh SW
    Pediatrics; 1970 Feb; 45(2):236-45. PubMed ID: 5413385
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrogenic diabetes insipidus associated with massive hydronephrosis and bladder neck obstruction.
    Ramsey EW; Morrin PA; Bruce AW
    J Urol; 1974 Feb; 111(2):225-8. PubMed ID: 4810771
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term ADH-treatment of rats with genetic diabetes insipidus.
    Oster P; Homsy E; Möhring B; Möhring J
    Acta Endocrinol Suppl (Copenh); 1973; 173():154. PubMed ID: 4353558
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of DDAVP in children's diabetes insipidus].
    Raska B; Straková M; Holecek V
    Cesk Pediatr; 1973; 28(5):262-4. PubMed ID: 4710286
    [No Abstract]   [Full Text] [Related]  

  • 13. [Familial primary vasopressin resistant diabetes insipidus sensitive to biguanide].
    Villamor J; Hita J; Barreiro P; Ortiz Vázquez J; Vãzquez JJ
    Rev Clin Esp; 1971 Apr; 121(1):51-62. PubMed ID: 5563103
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of 1-beta-oxyethyl-2-phenyl-methyl-piperidine in 6 cases of diabetes insipidus in children].
    Mouzet MT; Balsan S; Royer P
    Arch Fr Pediatr; 1968 Feb; 25(2):189-201. PubMed ID: 5245334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of carbamoyl-dibenzo-azepine (Tegretol) in the therapy of diabetes insipidus].
    Delzant G; Serbaoun J; Krivitzky A
    Ann Endocrinol (Paris); 1971; 52(4):540-6. PubMed ID: 4333284
    [No Abstract]   [Full Text] [Related]  

  • 16. [Occult diabetes insipidus of a pitressin-resistant and familial type in infants. Presentation of a case].
    Gandullia E; Lignana E
    Minerva Pediatr; 1979 Mar; 31(6):429-34. PubMed ID: 470886
    [No Abstract]   [Full Text] [Related]  

  • 17. Salt and water metabolism and neurohypophyseal vasopressor activity in mice with hereditary nephrogenic diabetes insipidus.
    Naik DV
    Acta Endocrinol (Copenh); 1972 Mar; 69(3):434-44. PubMed ID: 5067010
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of vasopressin (Pitressin) administration on sodium, potassium and urea excretion in rats with and without diabetes insipidus (DI), with a note on the excretion of vasopressin in the DI rat.
    Laycock JF; Williams PG
    J Endocrinol; 1973 Jan; 56(1):111-20. PubMed ID: 4683404
    [No Abstract]   [Full Text] [Related]  

  • 19. Water and electrolyte balance in adrenalectomized rats with diabetes insipidus (Brattleboro strain) given antidiuretic hormone.
    Balment RJ; Henderson IW; Jones IC; Mosley W
    Gen Comp Endocrinol; 1977 Nov; 33(3):428-33. PubMed ID: 924133
    [No Abstract]   [Full Text] [Related]  

  • 20. The renin-aldosterone system in nephrogenic diabetes insipidus and the influence of hydrochlorothiazide and indomethacin.
    Andersen O; Jacobsen BB
    Acta Paediatr Scand; 1983 Sep; 72(5):717-20. PubMed ID: 6637470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.